Max Robinson
Direktor/Vorstandsmitglied bei Pilgrims' Friend Society
Vermögen: 808 011 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Max Robinson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Newcastle University
20
| College/University | Other Consumer Services | 20 |
| Public Company | Medical Specialties | 11 | |
Pilgrims' Friend Society
 Pilgrims' Friend Society Services to the Health IndustryHealth Services Pilgrims' Friend Society provides individual and family social services. The non-profit company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 1807. Stephen Hammersley has been the CEO of the company since 2015.
10
| Non-Profit Organization | Services to the Health Industry | 10 |
University of Aberdeen
7
| College/University | Other Consumer Services | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Max Robinson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CENTRICA PLC | Gas Distributors | Director/Board Member Director/Board Member | |
Northumbrian Water Group Ltd.
 Northumbrian Water Group Ltd. Water UtilitiesUtilities Northumbrian Water Group Ltd. is a holding company, which engages in the regulated water and sewerage business. It operates through the following segments: Northumbrian Water Limited, Water and Wastewater Contracts, and Other. The company was founded in 1989 and is headquartered in Durham, the United Kingdom. | Water Utilities | Director/Board Member Chief Executive Officer | |
Motif BioSciences, Inc.
 Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Amphion Capital Management LLC
 Amphion Capital Management LLC Investment ManagersFinance Amphion Capital Management LLC (Amphion Capital) is a venture capital firm subsidiary of Amphion Innovations Plc founded in 1995 by Richard Morgan and Robert Bertoldi. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| AMPHION INNOVATIONS PLC | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
| INDIVIOR PLC | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| SCHRODERS PLC | Investment Managers | Director/Board Member Director/Board Member | |
Vennworks LLC
 Vennworks LLC Financial ConglomeratesFinance Vennworks LLC provides investment services. The private company is based in New York, NY. The company was founded by Robert Joseph Bertoldi, Richard Cecil Eversfield Morgan. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
| SMITHS GROUP PLC | Electrical Products | Director/Board Member Human Resources Officer | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of London | College/University | Undergraduate Degree | |
| Cranfield University | College/University | Graduate Degree | |
| University of Durham | College/University | Doctorate Degree Corporate Officer/Principal | |
Oxford Immunotec Ltd.
 Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Medical Specialties | Chairman | |
| The University of Sheffield | College/University | Undergraduate Degree | |
| The University of Nottingham | College/University | Doctorate Degree | |
| INMARSAT PLC | Specialty Telecommunications | Corporate Officer/Principal | |
| Université Libre de Bruxelles | College/University | Masters Business Admin | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Investment Managers | Chairman | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Haptogen Ltd.
 Haptogen Ltd. Pharmaceuticals: MajorHealth Technology Haptogen Ltd. manufactures biopharmaceuticals products. The company was founded by Jim Reid in 2002 and is headquartered in Aberdeen, UK. | Pharmaceuticals: Major | Founder | |
NovaBiotics Ltd.
 NovaBiotics Ltd. Pharmaceuticals: MajorHealth Technology NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Cytosystems Ltd.
 Cytosystems Ltd. Medical/Nursing ServicesHealth Services Cytosystems Ltd. develops advanced diagnostic techniques for cancer. Its products include BladderLight, a urine-based screening and diagnostic solution for the detection of cancer of the bladder and the prostate. The company was founded by David Galloway in 2006 and is headquartered in Aberdeen, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Biotechnology | Founder | |
| Elmwood Sensors Ltd. | Corporate Officer/Principal | ||
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Nova R&D, Inc.
 Nova R&D, Inc. Aerospace & DefenseElectronic Technology Nova R&D, Inc. specializes in the design, development and marketing of detectors, ASICs, integrated circuits, instruments and imaging systems. The company was founded in May 1984 and is headquartered in Riverside, CA. | Aerospace & Defense | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| University of Natural Resources & Life Sciences | College/University | Corporate Officer/Principal | |
| DSC Ltd. (Michigan) | Director/Board Member | ||
| Baines Peter Consulting | Director/Board Member | ||
Kromek Ltd.
 Kromek Ltd. Medical SpecialtiesHealth Technology Part of Kromek Group Plc, Kromek Ltd. is a British company that manufactures and sells digital color x-ray and gamma ray detection and imaging products. The company is based in Sedgefield, UK and was founded in 2003. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
ROADMap Systems Ltd.
 ROADMap Systems Ltd. Tools & HardwareConsumer Durables ROADMap Systems Ltd. manufactures IT hardware. The company was founded by Daping Chu and is headquartered in Cambridge, the United Kingdom. | Tools & Hardware | Chief Executive Officer | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
The Academic Health Science Network for The North East
 The Academic Health Science Network for The North East Miscellaneous Commercial ServicesCommercial Services The Academic Health Science Network for The North East operates as an intermediary platform for cross-organizational work in the healthcare industry. The non-profit company is based in Newcastle-upon-Tyne, UK. The CEO of the British company is Nicola Wesley. | Miscellaneous Commercial Services | Chairman | |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chairman | |
| Apterna Ltd. | Director/Board Member | ||
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 36 |
| Vereinigte Staaten | 7 |
| Indien | 5 |
| Belgien | 2 |
| Japan | 2 |
Sektoral
| Health Technology | 19 |
| Finance | 10 |
| Consumer Services | 8 |
| Electronic Technology | 4 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 150 |
| Chairman | 41 |
| Corporate Officer/Principal | 39 |
| Independent Dir/Board Member | 35 |
| Chief Executive Officer | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Iain Mackay | 25 |
| Richard Morgan | 22 |
| Peter D. Williams | 21 |
| Maria Ginman-Horrell | 20 |
| Peter Bains | 19 |
| Heidi Mottram | 17 |
| Lawrence Kinet | 16 |
| David Archibald MacFarlane | 15 |
| Jerel Whittingham | 15 |
| Anne Minto | 11 |
| Andrew Justin Radcliffe Porter | 8 |
| Moir Lockhead | 7 |
| Arnab Basu | 6 |
| Che Connon | 5 |
| Derek Bulmer | 4 |
- Börse
- Insiders
- Max Robinson
- Unternehmensverbindungen
